Fig. 3From: Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective studyKaplan-Meir analysis of the occurrence of major adverse events. Survival without adverse events was significantly reduced in the aggressive treatment group (P = 0.002 by log-rank test)Back to article page